SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Mr. Pink's Picks: selected event-driven value investments

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mr. Pink who wrote (2714)9/8/1998 9:05:00 AM
From: RockyBalboa  Read Replies (2) of 18998
 
Tout and dace of the dead dogs is rolling on:

In Germany TRBD crossed 10 Mark which is $6.

And here:

'J'Accuse...'

Barrons and Short Seller Manuel Asensio Have smeared an innocent man..
NY,Sept. 8 /PRNewswire/--
... He is underwriter Peter Janssen, and he was blamed for the poor performance of two Dreyfus funds. Yet during the period in which Barrons's graphed the collapse of the two Dreyfus funds, the tree Janssen/Meyers backed medical stocks rose. The stock performnce helped -- not hurt -- Dreyfus Funds' performance, exactly opposite to what Barron's published.
...
Also overlooked was that Nasdaq reports that two of the three stocks, Chromatics Color Sciences (Nasdaq: CCSI) and the warrant and common stock of Cytoclonal Pharmaceutical (Nasdaq: CYPH) were being still currently depressed by short sellers who were failing to deliver borrowed shares on time, according to Nasdaq statistics. "This is naked short selling," Flaherty said. The third stock, MacroChem (Nasdaq: MCHM), is also under attack by short sellers.
...

Source: EQUITIES Magazine LLC

(Full Story at PRNewswire, the Author appears to be "Robert J. Flaherty")

Single musicians joining an orchester to make up for a new pump?

Christian
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext